Literature DB >> 30548595

Mandibular osteotomy-induced hypoxia enhances osteoclast activation and acid secretion by increasing glycolysis.

Yi Tang1,2, Jie Zhu1,2, Danqing Huang3, Xiu Hu1,2, Yun Cai1,2, Xiwen Song1,2, Zhaohui Song1,2, Chaoyue Hong1,2, Zifan Feng1,2, Feiwu Kang1,2.   

Abstract

The rapid bone remodeling after osteotomy has been reported for a long time. However, the underlying mechanism promoting the active bone reconstruction was still to be elucidated. Since not only the bone, blood vessels, and supportive tissues, but also the local microenvironment were destroyed, if the changes on the cell metabolism was contributed to the accelerated bone remodeling came into sight. In present study, we found that the mandibular osteotomy in rabbit activated osteoclasts, as well as the expression of hypoxia-inducible factor 1α (HIF-1α) in alveolar bone. Hypoxia or HIF-1α could enhanced osteoclastogenesis, bone absorption, and lactic acid concentration in receptor activator of nuclear factor κΒ ligand-induced RAW264.7 cells. Coincided with the upregulated HIF-1α expression, HIF-driven glycolytic enzymes, such as lactate dehydrogenase A (LDHA), glucokinase (GCK), pyruvate kinase M2 (PKM2), and phosphofructokinase1 (PFK1), were found massively increased in both hypoxic RAW264.7 cells and the alveolar HIF-1α-positive osteoclasts after mandibular osteotomy. Knockdown of HIF-1α suppressed not only the hypoxia-mediated glycolysis, but also the hypoxia-induced acid secretion and bone resorption in RAW264.7 cells. Application of inhibitor on glycolysis gave rise to the similar results as HIF-1α knockdown. Our findings suggested that hypoxia-driven glycolysis in osteoclasts was an adaptive mechanism to permit alveolar bone remodeling after mandibular osteotomy.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  HIF-1α; bone resorption; glycolysis; mandibular osteotomy; osteoclast

Mesh:

Substances:

Year:  2018        PMID: 30548595     DOI: 10.1002/jcp.27765

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  6 in total

Review 1.  Metabolism and immunity in breast cancer.

Authors:  Deyu Zhang; Xiaojie Xu; Qinong Ye
Journal:  Front Med       Date:  2020-10-19       Impact factor: 4.592

2.  LncRNA-mRNA Expression Profiles of Osteoclast After Conditional Knockout HIF-1α.

Authors:  Yuanye Tian; Qi Shao; Jiahong Gu; Yi Tang; Miaomiao Bie; Yangyifan Zhou; Chunan Cheng; Yi Liang; Qian Zhang; Feiwu Kang
Journal:  Front Genet       Date:  2022-06-21       Impact factor: 4.772

Review 3.  The effect of long non-coding RNAs in joint destruction of rheumatoid arthritis.

Authors:  Hanxiao Zhao; Li Li; Ning Zhao; Aiping Lu; Cheng Lu; Xiaojuan He
Journal:  Front Cell Dev Biol       Date:  2022-10-03

Review 4.  The Role of Osteoclast Energy Metabolism in the Occurrence and Development of Osteoporosis.

Authors:  Wacili Da; Lin Tao; Yue Zhu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-12       Impact factor: 5.555

5.  Association of gut microbiota composition and function with an aged rat model of senile osteoporosis using 16S rRNA and metagenomic sequencing analysis.

Authors:  Sicong Ma; Jinhong Qin; Yongqiang Hao; Lingjie Fu
Journal:  Aging (Albany NY)       Date:  2020-06-02       Impact factor: 5.682

6.  Inhibition of PFKFB3 suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss.

Authors:  Jia Wang; Hanfeng Guan; Hui Liu; Zuowei Lei; Honglei Kang; Qian Guo; Yimin Dong; Huiyong Liu; Yunlong Sun; Zhong Fang; Feng Li
Journal:  J Cell Mol Med       Date:  2019-12-27       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.